z-logo
Premium
Young age is not associated with increased local recurrence for DCIS treated by breast‐conserving surgery and radiation
Author(s) -
Turaka Aruna,
Freedman Gary M.,
Li Tianyu,
Anderson Penny R.,
Swaby Ramona,
Nicolaou Nicos,
Goldstein Lori,
Sigurdson Elin R.,
Bleicher Richard J.
Publication year - 2009
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21284
Subject(s) - medicine , ductal carcinoma , breast conserving surgery , confidence interval , tamoxifen , radiation therapy , demographics , adjuvant radiotherapy , surgery , mastectomy , breast cancer , cancer , demography , sociology
Background We report local recurrence (LR) after breast‐conserving surgery and radiation (BCS + RT) for ductal carcinoma in situ (DCIS) to determine outcomes for patients aged ≤40 years compared with older women. Methods The study included 440 women with DCIS treated from 1978 to 2007. All patients received whole‐breast radiotherapy with a boost in 95% of cases. Demographics, characteristics, surgical, and adjuvant treatments were analyzed for an effect on LR. Results Median age was 56.5 years with 24 patients aged ≤40. Median DCIS size was 0.8 cm. Re‐excision was required in 62% of patients, and in 75% of those aged ≤40. Tamoxifen was used in 22%, but only one patient aged ≤40. Median follow‐up was 6.8 years. Actuarial LR was 7% (95% confidence interval of 4–11%) at 10 years and 8% (5–14%) at 15 years. There was no difference in LR by age ( P  = 0.76). Conclusions The long‐term risk of LR after BCS + RT for DCIS is low, even in patients ≤40 years. This may be due to patient selection for small size, high utilization of re‐excision, and radiation boost. Young age may be a smaller contributor to LR risk in DCIS than previously suggested. J. Surg. Oncol. 2009;100:25–31. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom